These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10373475

  • 1. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments.
    Dharmawardana KR, Olson ST, Bock PE.
    J Biol Chem; 1999 Jun 25; 274(26):18635-43. PubMed ID: 10373475
    [Abstract] [Full Text] [Related]

  • 2. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
    Dharmawardana KR, Bock PE.
    Biochemistry; 1998 Sep 22; 37(38):13143-52. PubMed ID: 9748321
    [Abstract] [Full Text] [Related]

  • 3. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
    Anderson PJ, Bock PE.
    J Biol Chem; 2003 Nov 07; 278(45):44489-95. PubMed ID: 12939270
    [Abstract] [Full Text] [Related]

  • 4. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
    Anderson PJ, Nesset A, Bock PE.
    J Biol Chem; 2003 Nov 07; 278(45):44482-8. PubMed ID: 12939269
    [Abstract] [Full Text] [Related]

  • 5. Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.
    Corral-Rodríguez MÁ, Bock PE, Hernández-Carvajal E, Gutiérrez-Gallego R, Fuentes-Prior P.
    Blood; 2011 Jun 30; 117(26):7164-73. PubMed ID: 21555742
    [Abstract] [Full Text] [Related]

  • 6. Exosite binding tethers the macromolecular substrate to the prothrombinase complex and directs cleavage at two spatially distinct sites.
    Boskovic DS, Krishnaswamy S.
    J Biol Chem; 2000 Dec 08; 275(49):38561-70. PubMed ID: 10984491
    [Abstract] [Full Text] [Related]

  • 7. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
    Bukys MA, Orban T, Kim PY, Beck DO, Nesheim ME, Kalafatis M.
    J Biol Chem; 2006 Jul 07; 281(27):18569-80. PubMed ID: 16624813
    [Abstract] [Full Text] [Related]

  • 8. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
    Verhamme IM, Olson ST, Tollefsen DM, Bock PE.
    J Biol Chem; 2002 Mar 01; 277(9):6788-98. PubMed ID: 11724802
    [Abstract] [Full Text] [Related]

  • 9. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ, Zingali RB.
    Thromb Haemost; 2002 Feb 01; 87(2):288-93. PubMed ID: 11858489
    [Abstract] [Full Text] [Related]

  • 10. HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase.
    Kretz CA, Stafford AR, Fredenburgh JC, Weitz JI.
    J Biol Chem; 2006 Dec 08; 281(49):37477-85. PubMed ID: 17046833
    [Abstract] [Full Text] [Related]

  • 11. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII.
    Esmon CT, Lollar P.
    J Biol Chem; 1996 Jun 07; 271(23):13882-7. PubMed ID: 8662922
    [Abstract] [Full Text] [Related]

  • 12. The role of thrombin exosites I and II in the activation of human coagulation factor V.
    Segers K, Dahlbäck B, Bock PE, Tans G, Rosing J, Nicolaes GA.
    J Biol Chem; 2007 Nov 23; 282(47):33915-24. PubMed ID: 17878169
    [Abstract] [Full Text] [Related]

  • 13. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA, Orban T, Kim PY, Nesheim ME, Kalafatis M.
    Thromb Haemost; 2008 Mar 23; 99(3):511-22. PubMed ID: 18327399
    [Abstract] [Full Text] [Related]

  • 14. Cleavage requirements for activation of factor V by factor Xa.
    Thorelli E, Kaufman RJ, Dahlbäck B.
    Eur J Biochem; 1997 Jul 01; 247(1):12-20. PubMed ID: 9249003
    [Abstract] [Full Text] [Related]

  • 15. Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.
    Bradford HN, Krishnaswamy S.
    J Biol Chem; 2019 Feb 15; 294(7):2422-2435. PubMed ID: 30578302
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V, Lemaire C, Bouton MC, Bezeaud A, Bon C, Guillin MC, Jandrot-Perrus M.
    Thromb Haemost; 1998 Jun 15; 79(6):1157-61. PubMed ID: 9657441
    [Abstract] [Full Text] [Related]

  • 17. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M, Rand MD, Mann KG.
    J Biol Chem; 1994 Dec 16; 269(50):31869-80. PubMed ID: 7989361
    [Abstract] [Full Text] [Related]

  • 18. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S, Walker RK.
    Biochemistry; 1997 Mar 18; 36(11):3319-30. PubMed ID: 9116010
    [Abstract] [Full Text] [Related]

  • 19. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA, Garrett M, Manuel RP, Nesheim ME, Giles AR.
    Blood; 1997 Aug 01; 90(3):1065-74. PubMed ID: 9242537
    [Abstract] [Full Text] [Related]

  • 20. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen.
    Hogg PJ, Jackson CM, Labanowski JK, Bock PE.
    J Biol Chem; 1996 Oct 18; 271(42):26088-95. PubMed ID: 8824251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.